Rajiv Kaul manages the Select Biotechnology Portfolio and Advisor Biotechnology Fund for Fidelity Investments. In his 17 years with Fidelity, Kaul has been widely recognized for his leadership within the biotech industry and often been ranked among the top U.S. healthcare investors. This year, he won the Lipper Award for the best three-year risk-adjusted performance in his sector. He is a member of the Research Advisory Council at Massachusetts General Hospital, the teaching hospital for Harvard Medical School. Kaul worked at McKinsey & Co. prior to joining Fidelity. He is a graduate of Harvard University.